Ad
related to: dipyridamole for breast cancerWorking to be "the most powerful patient advocate in America" - Forbes
- Over 70,000 Pharmacies
Accepted at Most Major Pharmacies
Search & Compare to Save Now
- Research You Can Rely On
Our team works hard to provide you
with the latest healthcare info.
- Visit Our FAQs
Have Questions? We've Got Answers.
See Our FAQs to Learn More Now!
- Do I Need Insurance?
No! Compare Our Prices to Your
Insurance & Get the Biggest Savings
- Over 70,000 Pharmacies
Search results
Results from the WOW.Com Content Network
Dipyridamole (trademarked as Persantine and others) is an antiplatelet drug of the nucleoside transport inhibitor and PDE3 inhibitor class that inhibits blood clot formation when given chronically and causes blood vessel dilation when given at high doses over a short time.
Scintimammography has a high sensitivity and specificity for breast cancer, both more than 85%. [ 7 ] More recently, breast radiologists administer lower doses of 99m Tc sestamibi (approximately 150–300 MBq or 4–8 mCi) for Molecular Breast Imaging (MBI) scans which results in a high sensitivity (91%) and high specificity (93%) for breast ...
Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.
C cell – c-erbB-2 – c-kit – CA 19-9 assay – CA-125 – CA-125 test – cachexia – calcitonin – calcitriol – CAM – Campath-1H – camptothecin – camptothecin analog – cancer – cancer induction – Cancer Information Service – cancer of unknown primary origin – cancer stem cell – cancer vaccine – Cancer.gov – Candidiasis – Candidosis – CAP-1 – capecitabine ...
Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. [1] Treatments can include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy including small-molecule drugs or monoclonal antibodies, [2] and PARP inhibitors such as olaparib. [3]
By conducting a meta-analysis of four large breast cancer trials including nearly 3,000 patients, the researchers have discovered that an abnormality on chromosome 17, called CEP17, is associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumor will respond to anthracyclines.
Invasive carcinoma NST accounts for half of all breast cancer diagnoses in women and is the most common type of invasive breast cancer. It is also the most commonly diagnosed form of male breast cancer. Invasive carcinoma NST is classified by its microscopic, molecular, and genetic features.
The estrogen diethylstilbestrol (DES) is occasionally used to treat prostate cancer through suppression of testosterone production. It was previously used in the treatment of breast cancer, but has been replaced by more effective and less toxic agents. Estrace is an estrogen which was also formerly used for antiandrogen therapy of prostate ...